Insider Selling: Prestige Consumer Healthcare Inc (PBH) EVP Sells $1,300,500.00 in Stock

Prestige Consumer Healthcare Inc (NYSE:PBH) EVP Timothy Connors sold 34,000 shares of the business’s stock in a transaction dated Monday, November 19th. The shares were sold at an average price of $38.25, for a total value of $1,300,500.00. Following the completion of the sale, the executive vice president now owns 25,775 shares in the company, valued at $985,893.75. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Timothy Connors also recently made the following trade(s):

  • On Wednesday, November 14th, Timothy Connors sold 74,707 shares of Prestige Consumer Healthcare stock. The shares were sold at an average price of $38.96, for a total value of $2,910,584.72.

Shares of PBH opened at $37.87 on Friday. Prestige Consumer Healthcare Inc has a twelve month low of $27.84 and a twelve month high of $48.24. The stock has a market cap of $1.95 billion, a PE ratio of 14.68, a P/E/G ratio of 1.87 and a beta of 1.04. The company has a current ratio of 2.15, a quick ratio of 1.38 and a debt-to-equity ratio of 1.59.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 1st. The company reported $0.65 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The firm had revenue of $239.36 million for the quarter, compared to analysts’ expectations of $236.28 million. During the same period in the prior year, the business posted $0.61 earnings per share. The company’s revenue was down 7.2% on a year-over-year basis. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc will post 2.88 earnings per share for the current fiscal year.

A number of equities research analysts recently issued reports on the company. Jefferies Financial Group set a $38.00 price objective on Prestige Consumer Healthcare and gave the company a “hold” rating in a research note on Thursday, August 2nd. DA Davidson upped their price target on Prestige Consumer Healthcare to $38.00 and gave the company a “neutral” rating in a research report on Monday, November 5th. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Thursday, October 11th. Finally, Zacks Investment Research reiterated a “hold” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, November 14th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. Prestige Consumer Healthcare presently has a consensus rating of “Hold” and an average target price of $72.40.

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. increased its position in shares of Prestige Consumer Healthcare by 6.7% during the second quarter. BlackRock Inc. now owns 6,350,034 shares of the company’s stock valued at $243,716,000 after buying an additional 400,781 shares during the period. FMR LLC increased its position in shares of Prestige Consumer Healthcare by 17.2% in the second quarter. FMR LLC now owns 5,880,226 shares of the company’s stock worth $225,683,000 after purchasing an additional 864,847 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Prestige Consumer Healthcare by 13.4% in the third quarter. Dimensional Fund Advisors LP now owns 3,629,692 shares of the company’s stock worth $137,530,000 after purchasing an additional 429,978 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Prestige Consumer Healthcare by 9.2% in the third quarter. JPMorgan Chase & Co. now owns 3,030,923 shares of the company’s stock worth $114,842,000 after purchasing an additional 255,561 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in shares of Prestige Consumer Healthcare by 19.3% in the second quarter. Wells Fargo & Company MN now owns 2,191,407 shares of the company’s stock worth $84,106,000 after purchasing an additional 354,122 shares during the last quarter.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Prestige Consumer Healthcare Inc (PBH) EVP Sells $1,300,500.00 in Stock” was first published by WKRB News and is the sole property of of WKRB News. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.wkrb13.com/2018/11/23/insider-selling-prestige-consumer-healthcare-inc-pbh-evp-sells-1300500-00-in-stock.html.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: Cost of Debt

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply